Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene.

Toyokawa G, Takenoyama M, Taguchi K, Toyozawa R, Inamasu E, Kojo M, Shiraishi Y, Morodomi Y, Takenaka T, Hirai F, Yamaguchi M, Seto T, Shimokawa M, Ichinose Y.

Lung Cancer. 2013 Sep;81(3):487-90. doi: 10.1016/j.lungcan.2013.05.022. Epub 2013 Jun 17.

PMID:
23787064
2.

Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.

Kanaji N, Bandoh S, Ishii T, Tadokoro A, Watanabe N, Takahama T, Haba R, Imataki O, Dobashi H, Matsunaga T.

Lung Cancer. 2012 Aug;77(2):293-8. doi: 10.1016/j.lungcan.2012.03.018. Epub 2012 Apr 10.

PMID:
22494566
3.

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

Lin E, Li L, Guan Y, Soriano R, Rivers CS, Mohan S, Pandita A, Tang J, Modrusan Z.

Mol Cancer Res. 2009 Sep;7(9):1466-76. doi: 10.1158/1541-7786.MCR-08-0522. Epub 2009 Sep 8.

4.

Correlation of anaplastic lymphoma kinase overexpression and the EML4-ALK fusion gene in non-small cell lung cancer by immunohistochemical study.

Chen TD, Chang IC, Liu HP, Wu YC, Wang CL, Chen YT, Chen YR, Huang SF.

Chang Gung Med J. 2012 Jul-Aug;35(4):309-17.

5.

A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.

Isozaki H, Yasugi M, Takigawa N, Hotta K, Ichihara E, Taniguchi A, Toyooka S, Hashida S, Sendo T, Tanimoto M, Kiura K.

Jpn J Clin Oncol. 2014 Oct;44(10):963-8. doi: 10.1093/jjco/hyu110. Epub 2014 Aug 28.

6.

Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.

Sanders HR, Li HR, Bruey JM, Scheerle JA, Meloni-Ehrig AM, Kelly JC, Novick C, Albitar M.

Cancer Genet. 2011 Jan;204(1):45-52. doi: 10.1016/j.cancergencyto.2010.08.024.

PMID:
21356191
7.

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

Wong DW, Leung EL, So KK, Tam IY, Sihoe AD, Cheng LC, Ho KK, Au JS, Chung LP, Pik Wong M; University of Hong Kong Lung Cancer Study Group.

Cancer. 2009 Apr 15;115(8):1723-33. doi: 10.1002/cncr.24181.

8.

EML4-ALK fusion gene in Korean non-small cell lung cancer.

Jin G, Jeon HS, Lee EB, Kang HG, Yoo SS, Lee SY, Lee JH, Cha SI, Park TI, Kim CH, Jheon SH, Park JY.

J Korean Med Sci. 2012 Feb;27(2):228-30. doi: 10.3346/jkms.2012.27.2.228. Epub 2012 Jan 27.

10.

Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.

Kobayashi M, Sakakibara T, Inoue A, Fukuhara T, Sasano H, Ichinose M, Nukiwa T.

Respir Investig. 2014 Jan;52(1):49-56. doi: 10.1016/j.resinv.2013.06.003. Epub 2013 Aug 1.

PMID:
24388371
11.

Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.

Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, Qitao Y.

Genes Chromosomes Cancer. 2012 Oct;51(10):925-32. doi: 10.1002/gcc.21976. Epub 2012 Jun 27.

PMID:
22736493
12.

The biology and treatment of EML4-ALK non-small cell lung cancer.

Sasaki T, Rodig SJ, Chirieac LR, Jänne PA.

Eur J Cancer. 2010 Jul;46(10):1773-80. doi: 10.1016/j.ejca.2010.04.002. Epub 2010 Apr 24. Review.

13.

A novel mass spectrometry-based assay for diagnosis of EML4-ALK-positive non-small cell lung cancer.

Sakai K, Okamoto I, Takezawa K, Hirashima T, Kaneda H, Takeda M, Matsumoto K, Kimura H, Fujita Y, Nakagawa K, Arao T, Nishio K.

J Thorac Oncol. 2012 May;7(5):913-8. doi: 10.1097/JTO.0b013e31824c7f7a.

14.

Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapy.

Morodomi Y, Takenoyama M, Inamasu E, Toyozawa R, Kojo M, Toyokawa G, Shiraishi Y, Takenaka T, Hirai F, Yamaguchi M, Taguchi K, Seto T, Sugio K, Ichinose Y.

Anticancer Res. 2014 Jul;34(7):3825-30.

PMID:
24982409
15.

Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene.

Fukui T, Yatabe Y, Kobayashi Y, Tomizawa K, Ito S, Hatooka S, Matsuo K, Mitsudomi T.

Lung Cancer. 2012 Aug;77(2):319-25. doi: 10.1016/j.lungcan.2012.03.013. Epub 2012 Apr 6.

PMID:
22483782
16.

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.

Martelli MP, Sozzi G, Hernandez L, Pettirossi V, Navarro A, Conte D, Gasparini P, Perrone F, Modena P, Pastorino U, Carbone A, Fabbri A, Sidoni A, Nakamura S, Gambacorta M, Fernández PL, Ramirez J, Chan JK, Grigioni WF, Campo E, Pileri SA, Falini B.

Am J Pathol. 2009 Feb;174(2):661-70. doi: 10.2353/ajpath.2009.080755. Epub 2009 Jan 15.

17.

Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Hamada T, Haruta H, Watanabe H, Kurashina K, Hatanaka H, Ueno T, Takada S, Yamashita Y, Sugiyama Y, Ishikawa Y, Mano H.

Cancer Res. 2008 Jul 1;68(13):4971-6. doi: 10.1158/0008-5472.CAN-07-6158.

18.

[Research progress in non-small cell lung cancer with concomitant EML4-ALK fusion gene and EGFR gene mutation].

Zeng Z, Wu Y.

Zhongguo Fei Ai Za Zhi. 2011 Nov;14(11):880-4. doi: 10.3779/j.issn.1009-3419.2011.11.09. Review. Chinese.

19.

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene.

Tanaka H, Hayashi A, Morimoto T, Taima K, Tanaka Y, Shimada M, Kurose A, Takanashi S, Okumura K.

BMC Cancer. 2012 Nov 26;12:558. doi: 10.1186/1471-2407-12-558.

20.

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutation.

Miyanaga A, Shimizu K, Noro R, Seike M, Kitamura K, Kosaihira S, Minegishi Y, Shukuya T, Yoshimura A, Kawamoto M, Tsuchiya S, Hagiwara K, Soda M, Takeuchi K, Yamamoto N, Mano H, Ishikawa Y, Gemma A.

BMC Cancer. 2013 May 29;13:262. doi: 10.1186/1471-2407-13-262.

Items per page

Supplemental Content

Write to the Help Desk